OPTIDRAIN
Live / Allowed — Second extension granted (statement of use) (as of 01 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99049685
- Mark type
- Stylized text
- Filed
- 20 Feb 2025
- Published for opposition
- 08 Apr 2025
Goods and services
- Class 005 — Pharmaceuticals: Ophthalmic pharmaceuticals, namely, eye drops, solutions, gels, and ointments used for the treatment of eye conditions, including dry eyes, allergies, infection, inflammation, redness and corneal swelling.
Owner
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
Prosecution history
- 02 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2026 — SOU EXTENSION 2 GRANTED
- 01 Jun 2026 — SOU EXTENSION 2 FILED
- 01 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Apr 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Apr 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 09 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 1 GRANTED
- 03 Dec 2025 — SOU EXTENSION 1 FILED
- 09 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 16 Feb 2026 — NOTICE OF REVIVAL - E-MAILED